Sort
40,608 grants matching “prostate cancer”
Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging.
$406,693Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2019 · CA
Controlled Release of Macromolecules
$406,614Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2009 · EB
Mechanisms of Normal Tissue Toxicity
$406,583Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Structure and Function of CTCF: Mouse Model Studies
$406,550Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA
Structure and Function of CTCF: Mouse Model Studies
$406,550Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
DETERMINANTS OF STEROID HORMONES IN BLACK AND WHITE MEN
$406,544Northwestern University · R01 · FY2000 · CA
Development of Castration Resistance by Alternative AR Splicing
$406,540Stephen R Plymate · Beth Israel Deaconess Medical Center · P01 · FY2013 · CA
Electromobility Focusing for Separation of Proteins
$406,531Brigham Young University · R01 · FY2003 · GM
Targeted nanotherapies for the treatment of prostate cancer
$406,520Anjali Sharma · Washington State University · R21 · FY2024 · CA
Development of a novel, targeted small molecule inhibitor of the nucleoside salvage pathway through murine studies to enable further clinical advancement in non-small-cell lung cancer
$406,500Kenneth Schultz · Trethera Corporation · R44 · FY2025 · CA
VIPCare: Virtual Predictive Care workflow with integrated surveillance for optimal care protocol selection and management in at-risk prostate cancer patients
$406,500Sharon Hensley Alford · Vizlitics Inc. · R43 · FY2023 · CA
Rapid and Automated Dissociation of Tumor Tissue for Single Cell Diagnostics
$406,500Ahmed Nabil Zobi · Syntr Health Technologies, Llc · R43 · FY2025 · TR
Investigating lineage plasticity in castration-resistant prostate cancer
$406,495Michael M. Shen · Columbia University Health Sciences · R01 · FY2024 · CA
Development of small molecule therapeutics targeting AR-V7 for prostate cancer
$406,489Cheuk Man Cherie Au · Arma Bio, Inc. · R42 · FY2024 · CA
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
$406,389Ram Shankar Mani · Ut Southwestern Medical Center · R01 · FY2020 · CA
Response and resistance to chimeric antigen receptor T cell therapy in human solid tumors using spatial multi-omics
$406,250Andrew John Rech · University Of Pennsylvania · DP5 · FY2025 · OD
Response and resistance to chimeric antigen receptor T cell therapy in human solid tumors using spatial multi-omics
$406,250Andrew John Rech · University Of Pennsylvania · DP5 · FY2024 · OD
Somatic Activation of Retrotransposition: A new Molecular Mechanism of Aging?
$406,250John M. Sedivy · Brown University · P01 · FY2019 · AG
Targeted prostate biopsy using mathematical optimization
$406,194University Of Pennsylvania · R01 · FY2005 · CA
CDK inhibitors in tumor progression
$406,170Andrew Koff · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Adipocyte regulation of tumor survival in metastatic prostate cancer: new targets for therapy
$406,167Izabela Podgorski · Wayne State University · R01 · FY2022 · CA
Bay Area Tumor Institute CCOP
$406,165James Feusner · Bay Area Tumor Institute · U10 · FY2011 · CA
Transgenic Animal Models for Prostate Cancer
$406,161Robert J Matusik · Vanderbilt University · R01 · FY2011 · CA
Human Steroid Metabolism by Cytochrome P450
$406,154Stephen G. Sligar · University Of Illinois At Urbana-Champaign · R01 · FY2015 · GM
Core 1: Mathematical Core
$406,144Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2023 · CA